Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, IT products, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics or the plasma market, visit our web site at http://www.haemonetics.com.
This release contains forward looking statements that involve risks and
uncertainties, including technological advances in the medical field and
standards for transfusion medicine and our ability to successfully
implement products that incorporate such advances and standards, product
demand, market acceptance, regulatory uncertainties, the effect of economic
and political conditions, the impact of competitive products and pricing,
blood product reimbursement policies and practices, foreign currency
exchange rates, changes in customers' ordering patterns, the effect of
industry consolidation as seen in the plasma market, the effect of
communicable diseases and the effect of u
|SOURCE Haemonetics Corporation|
Copyright©2007 PR Newswire.
All rights reserved